Fig. 2From: Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse modelCell cycle of Saos-2 cell treated with doxorubicin (a) and doxorubicin-conjugated BP NPs (b)Back to article page